VEGF signaling plays a key role in angiogenesis; blocking this pathway not only has antitumor effects but also leads to accelerated hypertension possibly via decreased nitric oxide bioavailability, increased endothelin-1 production, or microvascular rarefaction (Herrmann, 2020). The gene discussed is EDN1; the disease is Hypertension.